Directs the UNC Health Care System (UNCHCS) to modify its 340B program (a federal discount drug program) regarding its Disproportionate Share Hospital qualification, in cooperation with the Department of Public Safety, Health Services Section (DPS Health Services), and acquire necessary federal approval to provide HIV/AIDS and Hepatitis C medications to inmates. Requires UNCHCS and DPS Health Services to enter into a memorandum of understanding to modify and create policies and procedures regarding obtaining the medications. Directs UNCHCS and DPS Health Services to use telemedicine and the existing infectious disease clinics housed at Central Prison Healthcare Complex for treatment.
Directs the Office of State Budget and Management to transfer $25,000 for the 2018-19 fiscal year from DPS to UNCHCS to fund a legal consultant to assist with the 340B program design. Additionally allocates $7,000 of the DPS Health Services annual operating budget for federally required program auditing. Directs UNCHCS and DPS Health Services to develop a plan for obtaining additional costly medications such as drugs for cancer treatment through the 340B program.
Requires UNCHCS and DPS Health Services to report quarterly, beginning October 1, 2019, to the specified NCGA committees and division on the planned program implementation until a 340B program is in operation for purchasing HIV/AIDS and Hepatitis C medications.
Enacts GS 143B-707.5, creating an annual joint reporting requirement for UNCHCS and DPS Health Services containing annual savings achieved from purchasing inmate medications through a 340B program and any activities or plan to maintain or expand medications purchased through the program.
Directs DPS Health Services to revise its medication administration protocol to reflect that any supply of a prescription for the treatment of conditions other than HIV with a per-supply value of $1,000 or more be designated as Direct Observation Therapy. Directs DPS to report to the specified NCGA committee regarding the revised protocol by October 1, 2019.
Enacts GS 143B-707.6, requiring DPS Health Services to collect data on medication losses occurring during inmate transfer and develop internal controls to limit these losses, and investigate losses valued at more than $200. Further, requires DPS to establish disciplinary actions for staff found responsible for inmate medication losses during transfer. Makes DPS Health Services responsible for disciplinary action for their prison staff found responsible for medications lost during inmate transfers and directs DPS Health Services to refer incidents involving custody staff to the appropriate unit for action.
Directs DPS to conduct an internal audit of its processes for transferring medications during inmate transfer, specifically examining medications losses incurred during 2018-19 and including recommendations for improvement and more accountability. Requires DPS to submit the audit to the specified NCGA committee by December 1, 2019.
Enacts GS 143B-707.7, directing DPS Health Services to award a statewide contract to a private pharmacy for local purchases of inmate pharmacy needs by October 31, 2019. Requires prison health services staff to use the contracted pharmacy except under extenuating services and with the specified approval. Sets out procedures for DPS Health Services to collect information on all prescription purchases from the contracted pharmacy and outside pharmacy, and establish formal oversight mechanisms.
Directs DPS to report to the specified NCGA committee by November 1, 2019, on its efforts to award the required contract.
Effective July 1, 2019.
Bill Summaries: S825 PED/INMATE PHARMACY PURCHASING/MONITORING.
Printer-friendly: Click to view
Tracking:
-
Bill S 825 (2017-2018)Summary date: Nov 28 2018 - View Summary